Madrigal Pharmaceuticals, Inc. MDGL Total Revenue
Total Revenue at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s total revenue?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported total revenue of $311.34M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s total revenue changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s total revenue increased by 126.8% year-over-year, from $137.25M to $311.34M.
- What does total revenue mean?
- The total amount of money generated from business operations before any expenses are deducted.
- How do you interpret total revenue?
- An increase indicates growing market adoption and successful product commercialization, while a decrease suggests potential market saturation or competitive pressure.
- How does total revenue compare across companies?
- Peers in the commercial-stage biopharma space typically show high revenue growth rates as new therapies gain market share.